Latest News and Press Releases
Want to stay updated on the latest news?
-
RALEIGH, NC--(Marketwire - December 9, 2010) - Note to Reporters: Online News Conference today at 11am Eastern. To participate you'll need to call AND log on: Call...
-
WASHINGTON, DC--(Marketwire - December 6, 2010) - WHAT: A Webinar to unveil the "Responsible Use: Biotech Tree Principles" and discuss their intended worldwide use. Developed by...
-
OSLO, NORWAY--(Marketwire - November 18, 2010) - After further analyses of the international, randomized, double-blind, placebo-controlled multi-center phase IIb study of Bionor Pharma's (OSLO:...
-
WASHINGTON, DC--(Marketwire - November 18, 2010) - The Television, Internet and Video Association of DC (TIVA-DC) awarded WHITECOAT Strategies the gold medal for best public relations/marketing...
-
SYDNEY, AUSTRALIA--(Marketwire - September 20, 2010) - Pharmaceutical development company, Novogen Limited (ASX: NRT) (NASDAQ: NVGN) has appointed three new Directors. Of the three...
-
OSLO, NORWAY--(Marketwire - August 30, 2010) - Bionor Pharma (OSLO: BIONOR) today announced that Henrik Lund MD Ph.D, will take over the position of CEO from Trond Syvertsen effective from 1...
-
OSLO, NORWAY and WASHINGTON, DC--(Marketwire - August 30, 2010) - Study Highlights: 25 volunteers from previously conducted Phase 2a trial were "re-vaccinated" with the vaccine after 7...
-
SYDNEY, AUSTRALIA--(Marketwire - July 23, 2010) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) is listed on the Australian Stock Exchange and has an ADR program in place in the US through the...
-
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) - New data presented by researchers at the XVIII International AIDS Conference this week shows significant momentum for the emerging field of...
-
VIENNA, AUSTRIA--(Marketwire - July 22, 2010) - Researchers at Oslo University Hospital and Bionor Pharma's subsidiary, Bionor Immuno AS today presented results from a recently conducted...